-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Navidea Biopharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2023.
- Navidea Biopharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $9.44K, a 89.9% decline year-over-year.
- Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $291K, a 15.4% decline from 2021.
- Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $344K, a 1.55% increase from 2020.
- Navidea Biopharmaceuticals, Inc. annual Operating Lease, Payments for 2020 was $339K, a 2.73% increase from 2019.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)